Back to the main directory
EarningsReview / Equity
- SenSen Networks - Eyeing scalable growth through smart cities by Edison Investment Research
- Flying blind by BNP Paribas Exane
- GRIFOLS: 3Q’23 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Qualcomm (QCOM US) by HSBC
- Solid execution on FC 24 and Madden NFL 24 by BNP Paribas Exane
- Balder (Hold, TP: SEK48.00) - NIBD peak has passed by DnB Markets
- Humana (Hold, TP: SEK29.00) - Deleveraging remains in focus by DnB Markets
- TietoEVRY (Sell, TP: EUR19.00) - Estimates cut; SELL reiterated by DnB Markets
- Catena (Buy, TP: SEK425.00) - Still one of the best cases in the sector by DnB Markets
- Hexagon (Buy, TP: SEK135.00) - FCF keeps lid on share price by DnB Markets
- Momentum Group (Hold, TP: SEK110.00) - Solid sector roll-up strategy by DnB Markets
- AcadeMedia AB (Buy, TP: SEK63.00) - Updated capital allocation policy by DnB Markets
- Equinor (Buy, TP: NOK420.00) - Remains a stock to own into 2024 by DnB Markets
- Vår Energi (Buy, TP: NOK41.00) - On track to double production by DnB Markets
- Margin Collapse; Downgrade to Neutral by BNP Paribas Exane
- Korea E&Cs by HSBC
- Android channel normalization by BNP Paribas Exane
- VietNam Holding - Consistently outperforming the market by Edison Investment Research
- TUC (6274 TT) by HSBC
- Sylvania Platinum - Q124 production up, costs down by Edison Investment Research
- Chunghwa Telecom (2412 TT) by HSBC
- FQ3 First Take: Strong cost focus to drive high 2023 margin exit rate by BNP Paribas Exane
- 3Q23 pre-call takeaways by BNP Paribas Exane
- First Take: Modest 3Q23 Miss; 2023 EBIT Guide Unchanged Despite Lower EV Sales by BNP Paribas Exane
- 迈瑞医疗（300760 CH） by HSBC
- Aena - Upbeat 3Q23 on strong commercial, positive outlook by JB Capital Markets
- MercadoLibre (MELI US) by HSBC
- Grifols - Guidance upgraded and news on SRAAS by yearend; Buy by JB Capital Markets
- A Fig Newton in Motion Stays in Motion Unless... by BNP Paribas Exane
- Epiroc (Hold, TP: SEK200.00) - Hydraulic attachments detached by DnB Markets
- Vitrolife (Buy, TP: SEK250.00) - Mixed report by DnB Markets
- Metso (Buy, TP: EUR11.50) - Widespread misses by DnB Markets
- Coloplast (Buy, TP: DKK940.00) - Focus on margins by DnB Markets
- Fortnox (Buy, TP: SEK74.00) - Resetting growth expectations by DnB Markets
- Hexpol (Buy, TP: SEK125.00) - Cash flow generator at a discount by DnB Markets
- Alligo (Buy, TP: SEK135.00) - Solid business-improvement case by DnB Markets
- Truecaller (Buy, TP: SEK40.00) - Q4 de-risked by DnB Markets
- Aker BP (Buy, TP: NOK365.00) - Wind still in its sails by DnB Markets
- The weekly navigator by DnB Markets
- 3Q23 first take - results ahead, gold guidance trimmed by BNP Paribas Exane
- Airbnb Inc (ABNB US) by HSBC
- HYBE Corp (352820 KS) by HSBC
- Q323 earnings postview (+15 questions for management) by BNP Paribas Exane
- First Take: Lighter 3Q23 Amid Recoveries Timing; Guide Maintained, Signaling Weaker GoM by BNP Paribas Exane
- Read-x from Rockwell''s FY24e guidance by BNP Paribas Exane
- BGF Retail (282330 KS) by HSBC
- Paradigm Biopharma - Q1 results recap iPPS progress in OA & MPS by Edison Investment Research
- 3Q23 miss in Women''s Health and Biosimilars by BNP Paribas Exane
- Frasers Log & Comm Trust (FLT SP) by HSBC
- Aena - Reassuring message and CMD in 1Q24; Buy by JB Capital Markets